 Dice stock skyrocketed to a record high Tuesday after the biotech company unveiled promising early-stage test results for a psoriasis pill. The post Dice Therapeutics Surges To Record High As Psoriasis Pill Promises To Lead Its Class appeared first on Investors Business Daily. 